NN Investment Partners Holdings’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-293
Closed -$30K 630
2017
Q3
$30K Hold
293
﹤0.01% 703
2017
Q2
$30K Hold
293
﹤0.01% 914
2017
Q1
$34K Hold
293
﹤0.01% 836
2016
Q4
$35K Sell
293
-5,123
-95% -$567K ﹤0.01% 861
2016
Q3
$608K Sell
5,416
-9,303
-63% -$1.07M 0.01% 559
2016
Q2
$1.82M Sell
14,719
-3,469
-19% -$419K 0.02% 371
2016
Q1
$2.04M Buy
+18,188
New +$1.89M 0.02% 342

Other funds holding CLB

NN Investment Partners Holdings's CLB Position: Q4 2017 in Review

NN Investment Partners Holdings sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 293 shares — an estimated $30K sold.

NN Investment Partners Holdings first reported a position in CLB in Q1 2016 and held it in 7 quarters. The position peaked at $2.04M in Q1 2016. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • NN Investment Partners Holdings reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • NN Investment Partners Holdings sold 293 Core Laboratories shares in Q4 2017, an estimated $30K.
  • NN Investment Partners Holdings first reported a position in Core Laboratories in Q1 2016 and held it in 7 quarters.
  • NN Investment Partners Holdings's Core Laboratories position peaked at $2.04M in Q1 2016.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on NN Investment Partners Holdings's 13F filing for Q4 2017, filed 12 Feb 2018.